Report Publication Announcement • Oct 25, 2022
Report Publication Announcement
Open in ViewerOpens in native device viewer
Aker BioMarine ASA – Invitation to presentation of the third quarter 2022 results
Aker BioMarine will release the third quarter 2022 results on Tuesday 1 November 2022 at 07:00 CET.
At 09:00 CET on the same day, the management will host a webcast to present the results. Following a presentation, there will be a Q&A session where written questions can be submitted to [email protected].
The webcasted presentation will be in English. To join, please use the link that will be available at www.akerbiomarine.com/investor.
A replay of the presentation and Q&A session will be made available soon after the presentation at the same web page.
For further information, please contact
Carl Christian Bachke, Investor Relations
Mobile: +47 909 808 48
Email: [email protected]
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.